These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

990 related articles for article (PubMed ID: 25318641)

  • 1. Optimization of drug-drug interaction alert rules in a pediatric hospital's electronic health record system using a visual analytics dashboard.
    Simpao AF; Ahumada LM; Desai BR; Bonafide CP; Gálvez JA; Rehman MA; Jawad AF; Palma KL; Shelov ED
    J Am Med Inform Assoc; 2015 Mar; 22(2):361-9. PubMed ID: 25318641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of a clinical decision rule-based alert system for drug dose adjustment in patients with renal failure intended to improve pharmacists' analysis of medication orders in hospitals.
    Boussadi A; Caruba T; Karras A; Berdot S; Degoulet P; Durieux P; Sabatier B
    Int J Med Inform; 2013 Oct; 82(10):964-72. PubMed ID: 23831104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicians' responses to computerized drug-drug interaction alerts for outpatients.
    Yeh ML; Chang YJ; Wang PY; Li YC; Hsu CY
    Comput Methods Programs Biomed; 2013 Jul; 111(1):17-25. PubMed ID: 23608682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug safety alert generation and overriding in a large Dutch university medical centre.
    van der Sijs H; Mulder A; van Gelder T; Aarts J; Berg M; Vulto A
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):941-7. PubMed ID: 19579216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic approach to optimize electronic health record medication alerts in a health system.
    Bhakta SB; Colavecchia AC; Haines L; Varkey D; Garey KW
    Am J Health Syst Pharm; 2019 Apr; 76(8):530-536. PubMed ID: 31361861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial computerized provider order-entry system: Override appropriateness and adverse drug events.
    Edrees H; Amato MG; Wong A; Seger DL; Bates DW
    J Am Med Inform Assoc; 2020 Jun; 27(6):893-900. PubMed ID: 32337561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-drug interaction checking assisted by clinical decision support: a return on investment analysis.
    Helmons PJ; Suijkerbuijk BO; Nannan Panday PV; Kosterink JG
    J Am Med Inform Assoc; 2015 Jul; 22(4):764-72. PubMed ID: 25670751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reasons provided by prescribers when overriding drug-drug interaction alerts.
    Grizzle AJ; Mahmood MH; Ko Y; Murphy JE; Armstrong EP; Skrepnek GH; Jones WN; Schepers GP; Nichol WP; Houranieh A; Dare DC; Hoey CT; Malone DC
    Am J Manag Care; 2007 Oct; 13(10):573-8. PubMed ID: 17927462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug-drug interaction alerts.
    Baysari MT; Zheng WY; Li L; Westbrook J; Day RO; Hilmer S; Van Dort BA; Hargreaves A; Kennedy P; Monaghan C; Doherty P; Draheim M; Nair L; Samson R
    BMJ Open; 2019 Aug; 9(8):e026034. PubMed ID: 31427312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall performance of a drug-drug interaction clinical decision support system: quantitative evaluation and end-user survey.
    Van De Sijpe G; Quintens C; Walgraeve K; Van Laer E; Penny J; De Vlieger G; Schrijvers R; De Munter P; Foulon V; Casteels M; Van der Linden L; Spriet I
    BMC Med Inform Decis Mak; 2022 Feb; 22(1):48. PubMed ID: 35193547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' awareness of clinical decision support in pharmacy information systems: an exploratory evaluation.
    Hines LE; Saverno KR; Warholak TL; Taylor A; Grizzle AJ; Murphy JE; Malone DC
    Res Social Adm Pharm; 2011 Dec; 7(4):359-68. PubMed ID: 21530417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased appropriateness of customized alert acknowledgement reasons for overridden medication alerts in a computerized provider order entry system.
    Dekarske BM; Zimmerman CR; Chang R; Grant PJ; Chaffee BW
    Int J Med Inform; 2015 Dec; 84(12):1085-93. PubMed ID: 26428286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rising drug allergy alert overrides in electronic health records: an observational retrospective study of a decade of experience.
    Topaz M; Seger DL; Slight SP; Goss F; Lai K; Wickner PG; Blumenthal K; Dhopeshwarkar N; Chang F; Bates DW; Zhou L
    J Am Med Inform Assoc; 2016 May; 23(3):601-8. PubMed ID: 26578227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Investigation of Drug-Drug Interaction Alert Overrides at a Pediatric Hospital.
    Humphrey K; Jorina M; Harper M; Dodson B; Kim SY; Ozonoff A
    Hosp Pediatr; 2018 May; 8(5):293-299. PubMed ID: 29700011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of clinical support warnings through recategorization of severity levels.
    Parke C; Santiago E; Zussy B; Klipa D
    Am J Health Syst Pharm; 2015 Jan; 72(2):144-8. PubMed ID: 25550138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription order risk factors for pediatric dosing alerts.
    Stultz JS; Porter K; Nahata MC
    Int J Med Inform; 2015 Feb; 84(2):134-40. PubMed ID: 25466381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical evaluation of clinical decision support for the detection of drug-drug interactions.
    Smithburger PL; Buckley MS; Bejian S; Burenheide K; Kane-Gill SL
    Expert Opin Drug Saf; 2011 Nov; 10(6):871-82. PubMed ID: 21542665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practitioners' views on computerized drug-drug interaction alerts in the VA system.
    Ko Y; Abarca J; Malone DC; Dare DC; Geraets D; Houranieh A; Jones WN; Nichol WP; Schepers GP; Wilhardt M
    J Am Med Inform Assoc; 2007; 14(1):56-64. PubMed ID: 17068346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Turning off frequently overridden drug alerts: limited opportunities for doing it safely.
    van der Sijs H; Aarts J; van Gelder T; Berg M; Vulto A
    J Am Med Inform Assoc; 2008; 15(4):439-48. PubMed ID: 18436915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences among admitting departments in alerts and alert overrides for drug-drug interaction.
    Ahn EK; Kam HJ; Park DK; Jung EY; Lee Y; Park RW
    Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):390-7. PubMed ID: 24677664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.